3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Breast Neoplasms
17
Lymphoma
16
Multiple Myeloma
13
Neoplasm Metastasis
10
Leukemia, Myeloid, Acute
10
Melanoma
9
Lung Neoplasms
9
Prostatic Neoplasms
7
Carcinoma, Non-Small-Cell Lung
7
Squamous Cell Carcinoma of Head and Neck
6
Lymphoma, Non-Hodgkin
6
Triple Negative Breast Neoplasms
5
Pancreatic Neoplasms
5
Neuroblastoma
5
Leukemia, Lymphocytic, Chronic, B-Cell
5
Lymphoma, Follicular
4
Burkitt Lymphoma
4
Wilms Tumor
3
Small Cell Lung Carcinoma
3
Sarcoma, Kaposi
3
Sarcoma
3
Rhabdoid Tumor
3
Precursor Cell Lymphoblastic Leukemia-Lymphoma
3
Precancerous Conditions
3
Ovarian Neoplasms
3
Osteosarcoma
3
Neuroectodermal Tumors, Primitive, Peripheral
3
Myeloproliferative Disorders
3
Myelodysplastic Syndromes
3
Medulloblastoma
3
Interventions
fludarabine phosphate
2
Whole-Body Irradiation
2
Mycophenolic Acid
2
obinutuzumab
1
letermovir
1
carmustine, poliferprosan 20 drug combination
1
Tacrolimus
1
Stem Cell Transplantation
1
Peripheral Blood Stem Cell Transplantation
1
Melphalan
1
Hematopoietic Stem Cell Transplantation
1
Etoposide
1
Cytarabine
1
Cyclosporins
1
Cyclosporine
1
Cyclophosphamide
1
Carmustine
1
6-(1H-indazol-6-yl)-N-(4-morpholinophenyl)imidazo(1,2-a)pyrazin-8-amine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Leukemia, Prolymphocytic, B-Cell
×
Biopsy
×
Clear all
No trials found.